Table 4.
Antibiotics | Bacterial strains, MIC (μg/mL) of antibiotics in the absence and presence of 3′,4′,7-Trihydroxyflavone | ||||||
---|---|---|---|---|---|---|---|
Compounds concentration | PA124 | AG100Atet | EA289 | NEA16 | KP63 | PBSS (%) | |
CHL | 0 | 128 | 8 | 128 | 256 | 256 | |
MIC/2 | 16(0.125) S | 4(0.5) S | 128(1)I | 256(1)I | 256(1)I | 40 | |
MIC/4 | 32(0.25) S | 8(1)I | 128(1)I | 256(1)I | 256(1)I | 20 | |
CIP | 0 | 64 | 8 | > 64 | > 64 | > 64 | |
MIC/2 | 32(0.5) S | 4(0.5) S | > 64(≥ 1)I | > 64(≥ 1)I | 32(˂0.5) S | 60 | |
MIC/4 | 64(1)I | 8(1)I | > 64(≥ 1)I | > 64(≥ 1)I | > 64(≥ 1)I | 00 | |
TET | 0 | 16 | 16 | 32 | 64 | 4 | |
MIC/2 | 4(0.25) S | < 1(< 0.062) S | 64(2)I | 32(0.5) S | < 0.5(< 0.125) S | 80 | |
MIC/4 | 8(0.5) S | < 1(< 0.062) S | 64(2)I | 32(0.5) S | < 0.5(< 0.125) S | 80 | |
ERY | 0 | 128 | 8 | 128 | 256 | 8 | |
MIC/2 | 16(0.125) S | 4(0.5) S | 16(0.5) S | 128(0.5) S | 8(1)I | 80 | |
MIC/4 | 16(0.125) S | 8(1)I | 128(1)I | 128(0.5) S | 8(1)I | 40 | |
KAN | 0 | 128 | 4 | 8 | 32 | 32 | |
MIC/2 | 32(0.25) S | 4(1)I | 4(0.5) S | 32(1)I | 16(0.5) S | 60 | |
MIC/4 | 64(0.5) S | 4(1)I | 8(1)I | 32(1)I | 16(0.5) S | 40 | |
STR | 0 | 256 | > 256 | > 256 | 128 | 8 | |
MIC/2 | 16(0.0625) S | 256(< 1) S | > 256(≥ 1)I | 128(1)I | 4(0.5) S | 60 | |
MIC/4 | 32(0.125) S | > 256(≥ 1)I | > 256(≥ 1)I | 128(1)I | 8(1)I | 20 |
aAntibotics [TET tetracycline, CIP ciprofloxacin, STR streptomycin, KAN kanamycin, CHL chloramphenicol, ERY erythromycin]
bBacterial strains: Escherichia coli [AG100Atet], Pseudomonas aeruginosa [PA124], Enterobacter aerogenes [EA289], Klebsiella pneumonia [KP63], Providencia stuartii [NAE16]
cPBSS percentage of bacteria strain on which synergism has been observed, (): FIC (Fractional Inhibitory Concentration) of the antibiotics after association with compounds, S Synergy, I Indifference; The values in bold represent the cases of synergy between extract and antibiotic